Skip to main content

Rhabdovirus: Rabies

  • Chapter
  • First Online:
Viral Infections of Humans

Abstract

Rabies is an acute, progressive encephalitis of mammals and has the highest case fatality proportion of any conventional infectious disease. This disease is an ancient, reemerging global zoonosis, caused by highly neurotropic viruses in the family Rhabdoviridae, genus Lyssavirus [1].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 299.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Franka R, Rupprecht CE. Treatment of rabies in the 21st century: curing the incurable? Future Microbiol. 2011;6:1135–40.

    PubMed  Google Scholar 

  2. Wunner WH. Rabies virus. In: Jackson AC, Wunner WH, editors. Rabies. 2nd ed. London: Elsevier; 2007. p. 23–68.

    Google Scholar 

  3. Plotkin SA, Koprowski H, Rupprecht CE. Rabies vaccines. In: Plotkin SA, Orenstein WA, Offit PA, editors. Vaccines. 5th ed. New York: Springer; 2008. p. 687–714.

    Google Scholar 

  4. CDC. Compendium of animal rabies prevention and control. MMWR Morb Mortal Wkly Rep. 2011;60(RR-6):1–17.

    Google Scholar 

  5. CDC. Use of reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies. MMWR Morb Mortal Wkly Rep. 2010;59(No. RR-2):1–12.

    Google Scholar 

  6. Rupprecht CE, Hanlon CA, Hemachudha T. Rabies re-examined. Lancet Infect Dis. 2002;2:327–43.

    PubMed  Google Scholar 

  7. Dietzschold B, Schnell M, Koprowski H. Pathogenesis of rabies. Curr Top Microbiol Immunol. 2005;292:45–56.

    PubMed  CAS  Google Scholar 

  8. Hemachudha T. Human rabies: clinical aspects, pathogenesis, and potential therapy. In: Rupprecht CE, Dietzschold B, Koprowski H, editors. Lyssaviruses. New York: Springer; 1994. p. 121–43.

    Google Scholar 

  9. Fekadu M. Latency and aborted rabies. In: Baer GM, editor. The natural history of rabies. 2nd ed. Boca Raton: CRC Press; 1991. p. 191–200.

    Google Scholar 

  10. Fekadu M, Summer JW, Shaddock JH, et al. Sickness and recovery of dogs challenged with a street rabies virus after vaccination with a vaccinia virus recombinant expressing rabies virus N protein. J Virol. 1992;66:2601–4.

    PubMed  CAS  PubMed Central  Google Scholar 

  11. Rosner F. Rabies in the Talmud. Med Hist. 1974;18:198–200.

    PubMed  CAS  PubMed Central  Google Scholar 

  12. Steele JH, Fernandez PJ. History of rabies and global aspects. In: Baer GM, editor. The natural history of rabies. Boca Raton: CRC Press; 1991. p. 1–24.

    Google Scholar 

  13. Baer GM. Rabies – an historical perspective. Infect Agents Dis. 1994;3:168–80.

    PubMed  CAS  Google Scholar 

  14. Wilkinson L. The development of the virus concept as reflected in corpora of studies on individual pathogens. 4. Rabies – two millennia of ideas and conjecture on the aetiology of a virus disease. Med Hist. 1977;21:15–31.

    PubMed  CAS  PubMed Central  Google Scholar 

  15. Rupprecht CE, Dietzschold B, Wunner WH, et al. Antigenic relationships of lyssaviruses. In: Baer GM, editor. The natural history of rabies. Boca Raton: CRC Press; 1991. p. 69–100.

    Google Scholar 

  16. Smith JS, Orciari LA, Yager PA, et al. Epidemiologic and historical relationships among 87 rabies virus isolates as determined by limited sequence analysis. J Infect Dis. 1992;166:296–307.

    PubMed  CAS  Google Scholar 

  17. Smith JS, Fishbein DB, Rupprecht CE, et al. Unexplained rabies in three immigrants in the United States. A virologic investigation. N Engl J Med. 1991;324:205–11.

    PubMed  CAS  Google Scholar 

  18. Smith JS, Seidel HD. Rabies: a new look at an old disease. Prog Med Virol. 1993;40:82–8106.

    PubMed  CAS  Google Scholar 

  19. Bourhy H, Kissi B, Tordo N. Molecular diversity of the Lyssavirus genus. Virology. 1993;194:70–81.

    PubMed  CAS  Google Scholar 

  20. King AA, Meredith CD, Thomson GR. The biology of southern African lyssavirus variants. Curr Top Microbiol Immunol. 1994;187:267–95.

    PubMed  CAS  Google Scholar 

  21. Wiktor TJ. Historical aspects of rabies treatment. In: Koprowski H, Plotkin S, editors. World’s Debt to Pasteur. New York: Liss; 1985. p. 141–51.

    Google Scholar 

  22. Celis E, Rupprecht CE, Plotkin SA. New and improved vaccines against rabies. In: Woodrow GC, Levine MM, editors. New generation vaccines. New York: Marcel Dekker; 1990. p. 419–38.

    Google Scholar 

  23. Thraenhart O, Marcus I, Kreuzfelder E. Current and future immunoprophylaxis against human rabies: reduction of treatment failures and errors. Curr Top Microbiol Immunol. 1994;187:173–94.

    PubMed  CAS  Google Scholar 

  24. Briggs DJ, Schwenke JR. Longevity of rabies antibody titre in recipients of human diploid cell rabies vaccine. Vaccine. 1992;10:125–9.

    PubMed  CAS  Google Scholar 

  25. Wiktor TJ, Sokol F, Kuwert E, et al. Immunogenicity of concentrated and purified rabies vaccine of tissue culture origin. Proc Soc Exp Biol Med. 1975;131:799–805.

    Google Scholar 

  26. Goldwasser RA, Kissling RE. Fluorescent antibody staining of street and fixed rabies virus antigens. Proc Soc Exp Biol Med. 1958;98:219–23.

    PubMed  CAS  Google Scholar 

  27. Wandeler AI, Matter HC, Kappeler A, et al. The ecology of dogs and canine rabies: a selective review. Rev Sci Tech. 1993;12:51–71.

    PubMed  CAS  Google Scholar 

  28. Dyer J, Wallace R, Orciari LA, et al. Rabies surveillance in the United States during 2012. J Am Vet Med Assoc. 2013;243(6):805–15.

    PubMed  Google Scholar 

  29. Blanton JD, Palmer D, Dyer J, et al. Rabies surveillance in the United States during 2010. J Am Vet Med Assoc. 2011;239(6):773–83.

    PubMed  Google Scholar 

  30. Christian KA, Blanton JD, Auslander M, et al. Epidemiology of rabies post-exposure prophylaxis – United States of America, 2006–2008. Vaccine. 2009;27:7156–61.

    PubMed  Google Scholar 

  31. Smith JS. Rabies serology. In: Baer GM, editor. The natural history of rabies. 2nd ed. Boca Raton: CRC Press; 1991. p. 235–54.

    Google Scholar 

  32. Ma X, Niezgoda M, Blanton JD, et al. Evaluation of a new serological technique for detecting rabies virus antibodies following vaccination. Vaccine. 2012;30(36):5358–62.

    PubMed  CAS  Google Scholar 

  33. Hill RE, Beran GW, Clark WR. Demonstration of rabies virus-specific antibody in the sera of free-ranging Iowa raccoons (Procyon lotor). J Wildl Dis. 1992;28:377–85.

    PubMed  Google Scholar 

  34. Roess AA, Rea N, Lederman E, et al. National surveillance for human and pet contact with oral rabies vaccine baits, 2001-2009. J Am Vet Med Assoc. 2012;240:163–8.

    PubMed  Google Scholar 

  35. Nadin-Davis SA, Velez J, Malaga C, et al. A molecular epidemiological study of rabies in Puerto Rico. Virus Res. 2008;131:8–15.

    PubMed  CAS  Google Scholar 

  36. Linhart SB, Creekmore TE, Corn JL, et al. Evaluation of baits for oral rabies vaccination of mongooses: pilot field trials in Antigua, West Indies. J Wildl Dis. 1993;29:290–4.

    PubMed  CAS  Google Scholar 

  37. Organization WH. WHO expert committee on rabies—8th report. World Health Organ Tech Rep Ser. 1992;824:1–84.

    Google Scholar 

  38. Rudd RJ, Trimarchi CV. Development and evaluation of an in vitro virus isolation procedure as a replacement for the mouse inoculation test in rabies diagnosis. J Clin Microbiol. 1989;27:2522–8.

    PubMed  CAS  PubMed Central  Google Scholar 

  39. Coertse J, Nel LH, Sabeta CT, et al. A case study of rabies diagnosis from formalin-fixed brain material. J S Afr Vet Assoc. 2011;82:250–3.

    PubMed  CAS  Google Scholar 

  40. Lembo T, Niezgoda M, Velasco-Villa A, et al. Evaluation of a direct, rapid immunohistochemical test for rabies diagnosis. Emerg Infect Dis. 2006;12(2):310–3.

    PubMed  PubMed Central  Google Scholar 

  41. Niezgoda M, Rupprecht CE. Standard operating procedure for the direct rapid immunohistochemistry test for the detection of rabies virus antigen. National Laboratory Training Network Course. Atlanta: US Department of Health and Human Services, Centers for Disease Control and Prevention; 2006. p. 1–16.

    Google Scholar 

  42. Brito MG, Chamone TL, da Silva FJ, et al. Antemortem diagnosis of human rabies in a veterinarian infected when handling a herbivore in Minas Gerais, Brazil. Rev Inst Med Trop Sao Paulo. 2011;53:39–44.

    PubMed  Google Scholar 

  43. Smith JS. Rabies virus. In: Murray PR et al., editors. Manual of clinical microbiology. 6th ed. Washington, DC: ASM Press; 1995. p. 997–1003.

    Google Scholar 

  44. Kamolvarin N, Tirawatnpong T, Rattanasiwamoke R, et al. Diagnosis of rabies by polymerase chain reaction with nested primers. J Infect Dis. 1993;167(1):207–10.

    PubMed  CAS  Google Scholar 

  45. McColl KA, Gould AR, Selleck PW, et al. Polymerase chain reaction and other laboratory techniques in the diagnosis of long incubation rabies in Australia. Aust Vet J. 1993;70:84–9.

    PubMed  CAS  Google Scholar 

  46. Sacramento D, Bourhy H, Tordo N. PCR technique as an alternative method for diagnosis and molecular epidemiology of rabies virus. Mol Cell Probes. 1991;5:229–40.

    PubMed  CAS  Google Scholar 

  47. Bourhy H, Kissi B, Lafon M, et al. Antigenic and molecular characterization of bat rabies virus in Europe. J Clin Microbiol. 1992;30:2419–26.

    PubMed  CAS  PubMed Central  Google Scholar 

  48. Feiden W, Kaiser E, Gerhard L, et al. Immunohistochemical staining of rabies virus antigen with monoclonal and polyclonal antibodies in paraffin tissue sections. Zentralbl Veterinarmed B. 1988;35(4):247–55.

    PubMed  CAS  Google Scholar 

  49. Helmick CG, Tauxe RV, Vernon AA. Is there a risk to contacts of patients with rabies? Rev Infect Dis. 1987;9:511–8.

    PubMed  CAS  Google Scholar 

  50. Fekadu M, Endeshaw T, Alemu W, et al. Possible human-to-human transmission of rabies in Ethiopia. Ethiop Med J. 1996;34(2):123–7.

    PubMed  CAS  Google Scholar 

  51. Organization WH. Two rabies cases following corneal transplantation. Wkly Epidemiol Rec. 1994;69:330.

    Google Scholar 

  52. Vetter JM, Frisch L, Drosten C, et al. Survival after transplantation of corneas from a rabies-infected donor. Cornea. 2011;30:241–4.

    PubMed  Google Scholar 

  53. Srinivasan A, Burton EC, Kuehnert MJ, et al. Transmission of rabies virus from an organ donor to four transplant recipients. N Engl J Med. 2005;352:1103–11.

    PubMed  CAS  Google Scholar 

  54. Wandeler AI, Nadin-Davis SA, Tinline RR, et al. Rabies epidemiology: some ecological and evolutionary perspectives. Curr Top Microbiol Immunol. 1994;187:297–324.

    PubMed  CAS  Google Scholar 

  55. Artois M, Aubert M, Blancou J. Behavioral ecology of the transmission of rabies. Ann Rech Vet. 1991;22:163–72.

    PubMed  CAS  Google Scholar 

  56. CDC. Raccoon rabies epizootic—United States, 1993. MMWR Morb Mortal Wkly Rep. 1994;43:269–73.

    Google Scholar 

  57. Rupprecht CE, Smith JS. Raccoon rabies: the emergence of an epizootic in a densely populated area. Semin Virol. 1994;5:155–64.

    Google Scholar 

  58. Mallory LB. Campaign against rabies in Modoc and Lassen Counties. Calif State Board Health Mon Bull. 1915;11:273–7.

    Google Scholar 

  59. Clark KA, Neill SU, Smith JS, et al. Epizootic canine rabies transmitted by coyotes in south Texas. J Am Vet Med Assoc. 1994;204:536–40.

    PubMed  CAS  Google Scholar 

  60. Sidwa TJ, Wilson PJ, Moore GM, et al. Evaluation of oral rabies vaccination programs for control of rabies epizootics in coyotes and gray foxes: 1995-2003. J Am Vet Med Assoc. 2005;227:785–92.

    PubMed  Google Scholar 

  61. Velasco-Villa A, Reeder SA, Orciari LA, et al. Enzootic rabies elimination from dogs and reemergence in wild terrestrial carnivores, United States. Emerg Infect Dis. 2008;14(12):1849–54.

    PubMed  PubMed Central  Google Scholar 

  62. Charlton KM. The pathogenesis of rabies and other lyssaviral infections: recent studies. Curr Top Microbiol Immunol. 1994;187:95–119.

    PubMed  CAS  Google Scholar 

  63. Smith GL. Virus strategies for evasion of the host response to infection. Trends Microbiol. 1994;2:81–8.

    PubMed  CAS  Google Scholar 

  64. Gosztonyi G, Dietzschold B, Kao M, et al. Rabies and borna disease. A comparative pathogenetic study of two neurovirulent agents. Lab Invest. 1993;68:285–95.

    PubMed  CAS  Google Scholar 

  65. Schneider LG. Spread of virus within the central nervous system. In: Baer GM, editor. The natural history of rabies. New York: Academic; 1975. p. 199–216.

    Google Scholar 

  66. Shankar V, Dietzschold B, Koprowski H. Direct entry of rabies virus into the central nervous system without prior local replication. J Virol. 1991;65:2736–8.

    PubMed  CAS  PubMed Central  Google Scholar 

  67. Stöhr K, Meslin FM. Progress and setbacks in the oral immunisation of foxes against rabies in Europe. Vet Rec. 1996;139:32–5.

    PubMed  Google Scholar 

  68. Bourhy H, Dacheux L, Strady C, et al. Rabies in Europe in 2005. Euro Surveill. 2005;10:213–6.

    PubMed  CAS  Google Scholar 

  69. Carvalho-Costa FA, Tedesqui VL, de Jesus Nascimento Monteiro M, et al. Outbreaks of attacks by hematophagous bats in isolated riverine communities in the Brazilian Amazon: a challenge to rabies control. Zoonoses Public Health. 2012;59:272–7.

    PubMed  CAS  Google Scholar 

  70. Schneider MC, Santos-Burgoa C, Aron J, et al. Potential force of infection of human rabies transmitted by vampire bats in the Amazonian region of Brazil. Am J Trop Med Hyg. 1996;55:680–4.

    PubMed  CAS  Google Scholar 

  71. Rupprecht CE, Turmelle AS, Kuzmin IV. A perspective on lyssavirus emergence and perpetuation. Curr Opin Virol. 2011;1(6):662–70.

    PubMed  Google Scholar 

  72. Kuzmin IV, Novella IS, Dietzgen RG, et al. The rhabdoviruses: biodiversity, phylogenetics, and evolution. Infect Genet Evol. 2009;9(4):541–53.

    PubMed  CAS  Google Scholar 

  73. Banyard AC, Hayman D, Johnson N, et al. Bats and lyssaviruses. Adv Virus Res. 2011;79:239–89.

    PubMed  CAS  Google Scholar 

  74. Kuzmin IV, Turmelle AS, Agwanda B, et al. Commerson’s leaf-nosed bat (Hipposideros commersoni) is the likely reservoir of Shimoni bat virus. Vector Borne Zoonotic Dis. 2011;11:1465–70.

    PubMed  Google Scholar 

  75. Kuzmin IV, Mayer AE, Niezgoda M, et al. Shimoni bat virus, a new representative of the Lyssavirus genus. Virus Res. 2010;149:197–210.

    PubMed  CAS  Google Scholar 

  76. Childs JE, Colby L, Krebs JW, et al. Surveillance and spatiotemporal associations of rabies in rodents and lagomorphs in the United States, 1985-1994. J Wildl Dis. 1997;33:20–7.

    PubMed  CAS  Google Scholar 

  77. Nettles VF, Shaddock JH, Sikes RK, et al. Rabies in translocated raccoons. Am J Public Health. 1979;69:601–2.

    PubMed  CAS  PubMed Central  Google Scholar 

  78. CDC. First human death associated with raccoon rabies—Virginia, 2003. Morb Mortal Wkly Rep. 2009;52(45):1102–3.

    Google Scholar 

  79. Blanton JD, Dyer J, McBrayer J, et al. Rabies surveillance in the United States during 2011. J Am Vet Med Assoc. 2012;241:712–22.

    PubMed  Google Scholar 

  80. Fogelman V, Fischman HR, Horman JT, et al. Epidemiologic and clinical characteristics of rabies in cats. J Am Vet Med Assoc. 1993;202:1829–33.

    PubMed  CAS  Google Scholar 

  81. Brett W. Petersen and Charles E. Rupprecht (2011). Human Rabies Epidemiology and Diagnosis, Non-Flavivirus Encephalitis, Dr. Sergey Tkachev (Ed.), ISBN: 978-953-307-720-8, InTech, DOI: 10.5772/21708. Available from: http://www.intechopen.com/books/non-flavivirus-encephalitis/human-rabies-epidemiology-and-diagnosis.

    Google Scholar 

  82. Dietzschold B, Rupprecht CE, Tollis M, et al. Antigenic diversity of the glycoprotein and nucleocapsid proteins of rabies and rabies-related viruses: implications for epidemiology and control of rabies. Rev Infect Dis. 1988;10 Suppl 4:785–98.

    Google Scholar 

  83. Davlin SL, Vonville HM. Canine rabies vaccination and domestic dog population characteristics in the developing world: a systematic review. Vaccine. 2012;30:3492–502.

    PubMed  Google Scholar 

  84. CDC. Human rabies – Minnesota, 2007. Morb Mortal Wkly Rep. 2008;57(17):460–2.

    Google Scholar 

  85. CDC. Human rabies prevention—United States, 2008. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2008;57(No. RR-3):1–28.

    Google Scholar 

  86. Vora NM, Basavaraju SV, Feldman KA, et al. Racoon rabies virus variant transmission through solid organ transplantation. JAMA. 2013;310:398–407.

    PubMed  CAS  Google Scholar 

  87. A large-scale, rapid public health response to rabies in an organ recipient and the previously undiagnosed organ donor. Zoonoses Public Health. 2014 Mar 27. doi: 10.1111/zph.12105.

  88. Constantine DG. Rabies transmission by nonbite route. Public Health Rep. 1962;77:287–9.

    PubMed  CAS  PubMed Central  Google Scholar 

  89. CDC. Rabies in a laboratory worker—New York. Morb Mortal Wkly Rep. 1977;26:183–4.

    Google Scholar 

  90. Winkler WG, Fashinell TR, Leffingwell L, et al. Airborne rabies transmission in a laboratory worker. JAMA. 1973;226:1219–21.

    PubMed  CAS  Google Scholar 

  91. Johnson N, Phillpotts R, Fooks AR. Airborne transmission of lyssaviruses. J Med Microbiol. 2006;55:785–90.

    PubMed  CAS  Google Scholar 

  92. Charlton KM, Webster WA, Casey GA. Skunk rabies. In: Baer GM, editor. Natural history of rabies. 2nd ed. Boca Raton: CRC Press; 1991. p. 307–24.

    Google Scholar 

  93. Fu ZF, Weihe E, Zheng YM, et al. Differential effects of rabies and borna disease viruses on immediate-early- and late-response gene expression in brain tissues. J Virol. 1993;67:6674–81.

    PubMed  CAS  PubMed Central  Google Scholar 

  94. Balachandran A, Charlton K. Experimental rabies infection of non-nervous tissues in skunks (Mephitis mephitis) and foxes (Vulpes vulpes). Vet Pathol. 1994;31:93–9102.

    PubMed  CAS  Google Scholar 

  95. Jackson AC. Pathogenesis. In: Jackson AC, Wunner WH, editors. Rabies. 2nd ed. London: Elsevier; 2007. p. 341–72.

    Google Scholar 

  96. Hanlon CA, Niezgoda M, Rupprecht CE. Rabies in terrestrial animals. In: Jackson AC, Wunner WH, editors. Rabies. 2nd ed. London: Elsevier; 2007. p. 201–46.

    Google Scholar 

  97. Hill RE, Beran GW. Experimental inoculation of raccoons (Procyon lotor) with rabies virus of skunk origin. J Wildl Dis. 1992;28:51–6.

    PubMed  Google Scholar 

  98. Hill RE, Smith KE, Beran GW, et al. Further studies on the susceptibility of raccoons (Procyon lotor) to a rabies virus of skunk origin and comparative susceptibility of striped skunks (Mephitis mephitis). J Wildl Dis. 1993;29:475–7.

    PubMed  Google Scholar 

  99. Baer GM, Shaddock JH, Quirion R, et al. Rabies susceptibility and acetylcholine receptor. Lancet. 1990;335:664–5.

    PubMed  CAS  Google Scholar 

  100. Rupprecht CE, Dietzschold B. Perspectives on rabies virus pathogenesis. Lab Invest. 1987;57:603–6.

    PubMed  CAS  Google Scholar 

  101. Rupprecht CE, Hamir AN, Johnston DH, et al. Efficacy of a vaccinia-rabies glycoprotein recombinant virus vaccine in raccoons (Procyon lotor). Rev Infect Dis. 1988;10 Suppl 4:803–9.

    Google Scholar 

  102. Dietzschold B, Wang HH, Rupprecht CE, et al. Induction of protective immunity against rabies by immunization with rabies virus ribonucleoprotein. Proc Natl Acad Sci U S A. 1987;84:9165–9.

    PubMed  CAS  PubMed Central  Google Scholar 

  103. Dietzschold B, Tollis M, Rupprecht CE, et al. Antigenic variation in rabies and rabies-related viruses: cross-protection independent of glycoprotein-mediated virus-neutralizing antibody. J Infect Dis. 1987;156:815–22.

    PubMed  CAS  Google Scholar 

  104. Tollis M, Dietzschold B, Volia CB, et al. Immunization of monkeys with rabies ribonucleoprotein (RNP) confers protective immunity against rabies. Vaccine. 1991;9:134–6.

    PubMed  CAS  Google Scholar 

  105. Aubert MF, Masson E, Artois M, et al. Oral wildlife rabies vaccination field trials in Europe, with recent emphasis on France. Curr Top Microbiol Immunol. 1994;187:219–43.

    PubMed  CAS  Google Scholar 

  106. Brouchier B, Kieny MP, Costy F, et al. Large-scale eradication of rabies using recombinant vaccinia-rabies vaccine. Nature. 1991;354:520–2.

    Google Scholar 

  107. Wandeler AI. Oral immunization of wildlife. In: Baer GM, editor. The natural history of rabies. Boca Raton: CRC Press; 1991. p. 485–503.

    Google Scholar 

  108. Organization WH. Oral immunization of foxes in Europe in 1994. Wkly Epidemiol Rec. 1995;70:89–91.

    Google Scholar 

  109. Slate D, Algeo TP, Nelson KM, et al. Oral rabies vaccination in North America: opportunities, complexities, and challenges. PLoS Negl Trop Dis. 2009;3(12):e549. doi: 10.1371/journal.pntd.0000549.

    Google Scholar 

  110. Held JR, Tierkel ES, Steele JH. Rabies in man and animals in the United States, 1946-65. Public Health Rep. 1967;82:1009–18.

    PubMed  CAS  PubMed Central  Google Scholar 

  111. Dreesen DW. Animal vaccines. In: Jackson AC, Wunner WH, editors. Rabies. 2nd ed. London: Elsevier; 2007. p. 517–30.

    Google Scholar 

  112. Lembo T, Attlan M, Bourhy H, et al. Renewed global partnerships and redesigned roadmaps for rabies prevention and control. Vet Med Int. 2011;2011:923149.

    PubMed  PubMed Central  Google Scholar 

  113. Prevention PfR. Blueprint for rabies prevention and control. August 2010. Available at: http://www.rabiesblueprint.com/.

  114. Kieny MP, Lathe R, Drillien R, et al. Expression of the rabies virus glycoprotein from a recombinant vaccinia virus. Nature. 1984;312:163–6.

    PubMed  CAS  Google Scholar 

  115. Wiktor TJ, MacFarlan RI, Reagan KJ, et al. Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene. Proc Natl Acad Sci U S A. 1984;81:7194–8.

    PubMed  CAS  PubMed Central  Google Scholar 

  116. Wiktor TJ, MacFarlan RI, Dietzschold B, et al. Immunogenic properties of vaccinia recombinant virus expressing the rabies glycoprotein. Ann Inst Past/Virol. 1985;136E:405–11.

    Google Scholar 

  117. Rupprecht CE, Wiktor TJ, Johnston DH, et al. Oral immunization and protection of raccoons (Procyon lotor) with a vaccinia-rabies glycoprotein recombinant virus vaccine. Proc Natl Acad Sci U S A. 1986;83:7947–50.

    PubMed  CAS  PubMed Central  Google Scholar 

  118. Blancou J, Kieny MP, Lathe R, et al. Oral vaccination of the fox against rabies using a live recombinant vaccinia virus. Nature. 1986;332:373–5.

    Google Scholar 

  119. Pastoret PP, Brouchier B, Languet B, et al. First field trial of fox vaccination against rabies using a vaccinia-rabies recombinant virus. Vet Rec. 1988;123:481–3.

    PubMed  CAS  Google Scholar 

  120. Rupprecht CE, Hanlon CA, Hamir AN, et al. Oral wildlife rabies vaccination: development of a recombinant virus vaccine. In: McCabe RE, editor. Transactions of the 57th North American Wildlife and Natural Resources Conference—1992. Washington, DC: Wildlife Management Institute; 1992. p. 439–52.

    Google Scholar 

  121. Tolson ND, Charlton K, Stewart RB, et al. Immune response in skunks to a vaccinia virus recombinant expressing the rabies virus glycoprotein. Can J Vet Res. 1987;52:363–6.

    Google Scholar 

  122. Tolson ND, Charlton K, Casey GA, et al. Immunization of foxes against rabies with a vaccinia recombinant virus expressing the rabies glycoprotein. Arch Virol. 1990;102:297–301.

    Google Scholar 

  123. Thomas I, Brochier B, Languet B, et al. Primary multiplication site of the vaccinia-rabies glycoprotein recombinant virus administered to foxes by the oral route. J Gen Virol. 1990;71(Pt 1):37–42.

    PubMed  Google Scholar 

  124. Hanlon CA, Hayes DE, Hamir AN, et al. Proposed field evaluation of a rabies recombinant vaccine for raccoons (Procyon lotor): site selection, target species characteristics, and placebo baiting trials. J Wildl Dis. 1989;25:555–67.

    PubMed  CAS  Google Scholar 

  125. Hanlon CA, Buchanan JR, Nelson E, et al. A vaccinia-vectored rabies vaccine field trial: ante- and post-mortem biomarkers. Rev Sci Tech. 1993;12:99–9107.

    PubMed  CAS  Google Scholar 

  126. Rupprecht CE, Charlton KM, Artois M, et al. Ineffectiveness and comparative pathogenicity of attenuated rabies virus vaccines for the striped skunk (Mephitis mephitis). J Wildl Dis. 1990;26:99–9102.

    PubMed  CAS  Google Scholar 

  127. Van Regenmortel MH, Fauquet CM, Bishop DHL, et al. Virus taxonomy: classification and nomenclature of viruses. Seventh report of the international committee on taxonomy of viruses. San Diego: Academic; 2000. p. 227–37.

    Google Scholar 

  128. Yarosh OK, Wandeler AI, Graham FL, et al. Human adenovirus type 5 vectors expressing rabies glycoprotein. Vaccine. 1996;14:1257–64.

    PubMed  CAS  Google Scholar 

  129. Knowles MK, Nadin-Davis SA, Sheen M, et al. Safety studies on an adenovirus recombinant vaccine for rabies (AdRG1.3-ONRAB) in target and non-target species. Vaccine. 2009;27:6619–26.

    PubMed  CAS  Google Scholar 

  130. Knowles MK, Roberts D, Craig S, et al. In vitro and in vivo genetic stability studies of a human adenovirus type 5 recombinant rabies glycoprotein vaccine (ONRAB). Vaccine. 2009;27(20):2662–8.

    PubMed  CAS  Google Scholar 

  131. Aubert M. Control of rabies in foxes: what are the appropriate measures? Vet Rec. 1994;134:55–9.

    PubMed  CAS  Google Scholar 

  132. Cho HC, Lawson KF. Protection of dogs against death from experimental rabies by postexposure administration of rabies vaccine and hyperimmune globulin (human). Can J Vet Res. 1989;53:434–7.

    PubMed  CAS  PubMed Central  Google Scholar 

  133. Wilson PJ, Oertli EH, Hunt PR, et al. Evaluation of a postexposure rabies prophylaxis protocol for domestic animals in Texas: 2000-2009. J Am Vet Med Assoc. 2010;237:1395–401.

    PubMed  Google Scholar 

  134. Blancou J, Baltazar RS, Molli I, et al. Effective postexposure treatment of rabies-infected sheep with rabies immune globulin and vaccine. Vaccine. 1991;9:432–7.

    PubMed  CAS  Google Scholar 

  135. Fishbein DB, Bernard KW, Miller KD, et al. The early kinetics of the neutralizing antibody response after booster immunizations with human diploid cell rabies vaccine. Am J Trop Med Hyg. 1986;35:663–70.

    PubMed  CAS  Google Scholar 

  136. CDC. Human rabies—Kenya. Morb Mortal Wkly Rep. 1983;32:494–5.

    Google Scholar 

  137. Services DoHaH. Public Health Service Centers for Disease Control and Prevention. National Institutes of Health HHS Publication No. (CDC) 21-1112. Revised Dec 2009.

    Google Scholar 

  138. Xiang ZW, Spitalink S, Tran M, et al. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology. 1994;199:132–40.

    PubMed  CAS  Google Scholar 

  139. Schumacher CL, Dietzschold B, Ertl HC, et al. Use of mouse anti-rabies monoclonal antibodies in postexposure treatment of rabies. J Clin Invest. 1989;84:971–5.

    PubMed  CAS  PubMed Central  Google Scholar 

  140. Rupprecht CE, Shankar V, Hanlon CA, et al. Beyond Pasteur to 2001: future trends in lyssavirus research? In: Rupprecht CE, Dietzschold B, Koprowski H, editors. Lyssaviruses. New York: Springer; 1994. p. 325–40.

    Google Scholar 

  141. Lafon M, Lafage M. Antiviral activity of monoclonal antibodies specific for the internal proteins N and NS of rabies virus. J Gen Virol. 1987;68(Pt 12):3113–23.

    PubMed  Google Scholar 

  142. Meslin FX, Fishbein DB, Matter HC. Rationale and prospects for rabies elimination in developing countries. Curr Top Microbiol Immunol. 1994;187:1–26.

    PubMed  CAS  Google Scholar 

  143. Rupprecht CE, Dietzschold B, Campbell JB, et al. Consideration of inactivated rabies vaccines as oral immunogens of wild carnivores. J Wildl Dis. 1992;28:629–35.

    PubMed  CAS  Google Scholar 

  144. Wilde H, Chomchey P, Punyaratabandhu P, et al. Purified equine rabies immune globulin: a safe and affordable alternative to human rabies immune globulin. Bull World Health Organ. 1989;67:731–6.

    PubMed  CAS  PubMed Central  Google Scholar 

  145. Wilde H, Chutivongse S. Equine rabies immune globulin: a product with an undeserved poor reputation. Am J Trop Med Hyg. 1990;42:175–8.

    PubMed  CAS  Google Scholar 

  146. Quiambao BP, Dy-Tioco HZ, Dizon RM, et al. Rabies post-exposure prophylaxis with purified equine rabies immunoglobulin: one-year follow-up of patients with laboratory-confirmed category III rabies exposure in the Philippines. Vaccine. 2009;27:7162–6.

    PubMed  CAS  Google Scholar 

  147. Wilde H, Chomchey P, Prakongsri S, et al. Adverse effects of equine rabies immune globulin. Vaccine. 1989;7:10–1.

    PubMed  CAS  Google Scholar 

  148. Dietzschold B, Kao M, Zheng YM, et al. Delineation of putative mechanisms involved in antibody-mediated clearance of rabies virus from the central nervous system. Proc Natl Acad Sci U S A. 1992;89:7252–6.

    PubMed  CAS  PubMed Central  Google Scholar 

  149. Willoughby RE, Tieves KS, Hoffman GM, et al. Survival after treatment of rabies with induction of coma. N Engl J Med. 2005;352:2508–14.

    PubMed  CAS  Google Scholar 

  150. Mrak RE, Young L. Rabies encephalitis in humans: pathology, pathogenesis and pathophysiology. J Neuropathol Exp Neurol. 1994;53:1–10.

    PubMed  CAS  Google Scholar 

  151. Jackson AC. Therapy of human rabies. In: Jackson AC, editor. Advances in virus research. London: Elsevier; 2012. p. 365–75.

    Google Scholar 

  152. Boyle DB. Disease and fertility control in wildlife and feral animal populations: options for vaccine delivery using vectors. Reprod Fertil Dev. 1994;6:393–400.

    PubMed  CAS  Google Scholar 

  153. Wu X, Franka R, Svoboda P, et al. Development of combined vaccines for rabies and immunocontraception. Vaccine. 2009;27:7202–9.

    PubMed  CAS  Google Scholar 

  154. CDC. CDC health information for international travel 2012. New York: Oxford University Press; 2012.

    Google Scholar 

  155. Kuzmin IV, Tordo N. Genus Lyssavirus. In: Dietzgen RG, Kuzmin IV, editors. Rhabdoviruses, molecular taxonomy, evolution, genomics, ecology, host-vector Interactions, cytopathology and control. Norfolk: Caister Academic Press; 2012. p. 37–57.

    Google Scholar 

Download references

Acknowledgments

The authors would like to thank Jesse D. Blanton and Jessie L. Dyer for their assistance in the preparation of this manuscript.

Disclaimer

The findings and conclusions in this chapter are those of the authors and do not necessarily represent the view of the Centers for Disease Control and Prevention.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kira A. Christian DVM, MPH .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Christian, K.A., Rupprecht, C.E. (2014). Rhabdovirus: Rabies. In: Kaslow, R., Stanberry, L., Le Duc, J. (eds) Viral Infections of Humans. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-7448-8_28

Download citation

  • DOI: https://doi.org/10.1007/978-1-4899-7448-8_28

  • Published:

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4899-7447-1

  • Online ISBN: 978-1-4899-7448-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics